摘要
肝细胞肝癌行肝脏移植的指征、效果及相关问题一直存在争论。本文收集并分析近年国内外文献,结合我院近6年112例肝癌肝移植病例资料,对肝癌的分期标准及供肝分配原则、大肝癌行肝脏移植的指征、肝癌肝移植患者等待供肝时的处理、影响肝癌肝移植术后复发的预后因子及肝癌患者行肝切除还是行肝脏移植的选择原则等肝癌肝移植的相关问题进行探讨。笔者认为建立与评价适应我国肝癌肝移植的分期标准及手术指征是当务之急。
The indications, effectiveness, and other relevant problems of the orthotopic liver transplantation （OLT） for hepatocellular carcinoma （HCC） are still under controversy in our country. This article collects and analyzes resent published literatures as well as the clinical data of 112 patients who underwent OLT for HCC in our hospital, and tries to investigate the staging system of HCC, liver allocation policy for OLT, expanded criteria for OLT in HCC, tumor management when awaiting transplantation, prognostic factors of recurrence, and principles to make a choice between resection and transplantation in patients with HCC. It is most important to establish a staging system and transplantation indications for liver transplantation of HCC in China.
出处
《中国医学科学院学报》
CAS
CSCD
北大核心
2005年第4期427-430,共4页
Acta Academiae Medicinae Sinicae
关键词
肝细胞肝癌
原位肝脏移植
分期标准
手术指征
hepatocellular carcinoma
orthotopic liver transplantation
staging criteria
operative indication
